Brief: Passage Bio And Remix Therapeutics Announce Merger Agreement
24/06/2026 23:25
BRIEF-Passage Bio And Remix Therapeutics Announce Merger Agreement Passage Bio Inc PASG.O:
PASSAGE BIO AND REMIX THERAPEUTICS ANNOUNCE MERGER AGREEMENT
PASSAGE BIO - COMBINED COMPANY TO OPERATE AS REMIX THERAPEUTICS, TRADE AS RMTX ON NASDAQ
PASSAGE BIO - REMIX SECURES $100 MILLION OVERSUBSCRIBED PRIVATE PLACEMENT FINANCING
PASSAGE BIO - SHAREHOLDERS TO OWN 7%, REMIX STOCKHOLDERS 93% OF COMBINED COMPANY
PASSAGE BIO - DR. SMITH TO LEAD COMBINED COMPANY, MATTHEW PATTERSON TO CHAIR BOARD, PETER COLABUONO TO JOIN BOARD
Source text: ID:nGNX3J8Z
Further company coverage: PASG.O